<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb1f/7433097/81aa367d29b8/12881_2020_1103_Fig2_HTML.jpg"/> </div> <div class="text-side"> <h1>Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma.</h1> <p>Pathology from Olfactory Neuroblastoma. Histopathological images from the olfactory neuroblastoma (esthesioneuroblastoma) removed from our proband at surgery. Images shown are from the tumor tissue resected from the right frontal nasal sinus. Panel A shows a nest of tumor cells with the characteristic “salt and pepper” appearance (hematoxylin and eosin staining 40x). Panel B shows intense immunohistochemical staining for synaptophysin supporting the diagnosis of neuroblastoma (20x). Several other immunostains were done but not shown. Tumor cells were also positive for chromogranin, and negative for CAM 5.2, EMA, and CD45; GFAP is essentially negative in the matrix</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32807118/" target="_blank">32807118</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>